Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liz Fletcher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|December 26, 2001
Roche leads molecular diagnostics chargeLiz Fletcher
Nature Biotechnology|May 1, 2002
Investors remain wary after first quarter downturnLiz Fletcher
Nature Biotechnology|February 16, 2002
ImClone BLA is declinedLiz Fletcher
Nature Biotechnology|February 1, 2002
Amgen's big-ticket play for ImmunexLiz Fletcher
Nature Biotechnology|February 3, 2004
Genomics companies shop around for chemical expertiseLiz Fletcher
Nature Biotechnology|September 3, 2002
Pfizer-Pharmacia merger bodes ill for biotech?Liz Fletcher
Nature Biotechnology|June 29, 2002
Merlin's maestroLiz Fletcher
Nature Biotechnology|June 4, 2002
Public biotechnology 2001--the numbersRiku Lähteenmäki, Liz Fletcher
Biochemical Society Transactions|June 11, 2016
Exploring Synthetic and Systems Biology at the University of EdinburghLiz Fletcher, Susan Rosser, Alistair Elfick
Frontiers in Bioengineering and Biotechnology|August 27, 2019
Future Trends in Synthetic Biology-A ReportMeriem El Karoui, Monica Hoyos-Flight, Liz Fletcher
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|December 26, 2001
Roche leads molecular diagnostics chargeLiz Fletcher
Nature Biotechnology|May 1, 2002
Investors remain wary after first quarter downturnLiz Fletcher
Nature Biotechnology|February 16, 2002
ImClone BLA is declinedLiz Fletcher
Nature Biotechnology|February 1, 2002
Amgen's big-ticket play for ImmunexLiz Fletcher
Nature Biotechnology|February 3, 2004
Genomics companies shop around for chemical expertiseLiz Fletcher
Nature Biotechnology|September 3, 2002
Pfizer-Pharmacia merger bodes ill for biotech?Liz Fletcher
Nature Biotechnology|June 29, 2002
Merlin's maestroLiz Fletcher
Nature Biotechnology|June 4, 2002
Public biotechnology 2001--the numbersRiku Lähteenmäki, Liz Fletcher
Biochemical Society Transactions|June 11, 2016
Exploring Synthetic and Systems Biology at the University of EdinburghLiz Fletcher, Susan Rosser, Alistair Elfick
Frontiers in Bioengineering and Biotechnology|August 27, 2019
Future Trends in Synthetic Biology-A ReportMeriem El Karoui, Monica Hoyos-Flight, Liz Fletcher
Pageof 1